Cingulate Inc.
看多
已更新

$CING - Low Float - Positive Top Line Results - ADHD 1 PILL

46
We are traveling the bottom of the channel. I think it starts to move up shortly. Adolescent and Pediatric fixed dose phase 3 trials start this month and next month. FDA approval submission early/mid next year. Billion-dollar drug if it can get some funding? This is my own opinion, and you should not take any of this as financial advice.
註釋
Curious what this would mean for the current producers of such meds like JNJ, PFE, NVS? I'm assuming they would buy out Cingulate quickly before something like that dented their sales.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。